Spero Therapeutics
SPRO
SPRO
53 hedge funds and large institutions have $113M invested in Spero Therapeutics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $119M → $113M (-$6.14M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.38M | |
| 2 | +$4.62M | |
| 3 | +$4.2M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$4.03M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$1.91M | |
| 3 | -$181K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$56K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$24K |